Your session is about to expire
← Back to Search
Thoracotomy versus Thoracoscopic Management for Osteosarcoma
This trial compares the effect of open thoracic surgery to thoracoscopic surgery in treating patients with osteosarcoma that has spread to the lung.
- Lung Cancer
- Bone Sarcoma
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a Location
Who is running the clinical trial?
- You have a primary tumor that cannot be removed by surgery.You have metastatic lung cancer that is located in a part of the lung that would require surgery to remove or is located near the center of the lung.You had surgery to remove lung metastasis before joining the study.Patients must be < 50 years at the time of enrollment.You have lung nodules that are considered resectable by either open thoracotomy or thoracoscopic surgery.You have evidence of metastatic disease at the time of initial diagnosis, or at time of 1st recurrence following completion of therapy for initially localized disease.You are receiving systemic therapy considered by the treating physician as at least equivalent to methotrexate, doxorubicin and cisplatin (MAP) at the time of enrollment on this study.
- Group 1: Arm A (thoracotomy)
- Group 2: Arm B (thoracoscopy)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are investigators still signing up volunteers for this research project?
"This trial is currently looking for patients. The original posting date was February 15th, 2022 and the most recent update was on October 19th, 2022."
How many volunteers are being chosen for this opportunity?
"The most recent information available on clinicaltrials.gov indicates that this study is still recruiting patients. This trial was first posted on February 15th, 2022 and was last updated on October 19th, 2022. The goal is to enroll 250 participants from 100 different locations."
Is Thoracoscopy a high-risk procedure for patients?
"Thoracoscopy is classified as a safe medical procedure because it has received a score of 3. This means that multiple rounds of clinical trials have found it to be both effective and safe."
Who else is applying?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends